Hakim Rahmoune1,2*, Mounira Amrane1, Hadia Ziada-Bouchaar3,4, Dalila Satta3 and Nada Boutrid1,2
1LMCVGN Research Laboratory, Faculty of Medicine, Setif-1 University, Algeria
2Department of Pediatrics, University Hospital of Setif, Algeria
3Faculty of Natural and Life Sciences, Molecular and Cellular Biology Laboratory, University of Constantine 1 Mentouri Brothers, Constantine, Algeria
4Department of Animal Biology, Faculty of Natural and Life Science, University 1, Mentouri Brothers, Constantine, Algeria
*Corresponding Author: Hakim Rahmoune, LMCVGN Research Laboratory, Faculty of Medicine, Setif-1 University, Algeria.
Received: August 10, 2020; Published: August 24, 2020
Celiac disease (CD) and inflammatory bowel diseases (IBD) are among the most common gastrointestinal disorders and share strong genetic risks that may predict their diagnosis or even guide their management, particularly the Human Leukocyte Antigen (HLA) system.
Historically, various associations between the HLA and autoimmune diseases were reported since the 1970s, and the HLA is now incriminated in a myriad of diseases including CD and IBD [1,2].
Citation: Hakim Rahmoune., et al. “Back to the Future: HLA in Gastroenterology”. Acta Scientific Gastrointestinal Disorders 3.10 (2020): 01-02.
Copyright: © 2020 Hakim Rahmoune., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.